Shanghai Shen Lian Biomedical Corp (688098) — Cash Flow-to-Debt Ratio
Shanghai Shen Lian Biomedical Corp (688098) has a Cash Flow-to-Debt Ratio of 0.15x as of September 2025, meaning its operating cash flow of CN¥21.52 Million could theoretically repay 0% of its total liabilities (CN¥139.42 Million) in one year. See Shanghai Shen Lian Biomedical Corp (688098) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Shen Lian Biomedical Corp Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Shanghai Shen Lian Biomedical Corp across 13 annual periods. For the full cash flow conversion analysis, see 688098 cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for Shanghai Shen Lian Biomedical Corp (2013–2025)
Year-by-year debt coverage analysis for Shanghai Shen Lian Biomedical Corp. Check 688098 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | CN¥33.08 Million | CN¥143.41 Million | ▼ -66.8% |
| 2024 | 0.70x | CN¥89.36 Million | CN¥128.50 Million | ▲ +1614.7% |
| 2023 | 0.04x | CN¥3.53 Million | CN¥86.93 Million | ▼ -51.7% |
| 2022 | 0.08x | CN¥9.09 Million | CN¥108.21 Million | ▼ -88.3% |
| 2021 | 0.72x | CN¥90.12 Million | CN¥125.48 Million | ▼ -24.0% |
| 2020 | 0.95x | CN¥111.73 Million | CN¥118.20 Million | ▲ +192.2% |
| 2019 | 0.32x | CN¥53.81 Million | CN¥166.33 Million | ▼ -51.6% |
| 2018 | 0.67x | CN¥121.13 Million | CN¥181.18 Million | ▲ +28.1% |
| 2017 | 0.52x | CN¥74.61 Million | CN¥142.92 Million | ▲ +54.8% |
| 2016 | 0.34x | CN¥48.00 Million | CN¥142.32 Million | ▲ +88.9% |
| 2015 | 0.18x | CN¥30.86 Million | CN¥172.90 Million | ▼ -51.6% |
| 2014 | 0.37x | CN¥105.98 Million | CN¥287.32 Million | ▲ +45.3% |
| 2013 | 0.25x | CN¥51.79 Million | CN¥203.94 Million | — |